The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion…

ThrombocytopeniaNeonatalPlatelet Transfusion+4 more

~Estimated

~$10 – $7,500

NICHD Neonatal Research NetworkNCT06676904

Phase 1

Pharmacokinetics and Pharmacodynamics of Digoxin in Infants With Single Ventricle Heart Disease

The primary participant will be an infant with single ventricle heart disease. This is a research study to learn more about how the medication digoxin, which …

Single-ventricleInfant ConditionsInfant, Newborn, Diseases+1 more

~Estimated

~$10 – $6,250

Duke UniversityNCT06613477